Left Chamber Function in Mitral Regurgitation and Predicting Outcome After Replacement and Targeting for Early Surgery
Mitral Regurgitation
About this trial
This is an interventional diagnostic trial for Mitral Regurgitation focused on measuring mitral, regurgitation, speckle, echocardiography, replacement
Eligibility Criteria
Inclusion Criteria:
- Patients with rheumatic severe mitral regurgitation who will have mitral valve replacement in Assiut University Heart Hospital
Exclusion Criteria:
- Degenerative mitral regurgitation, ischemic mitral regurgitation, severe rheumatic mitral regurgitation with atrial fibrillation or impaired left ventricular ejection fraction, associated mitral stenosis, or significant aortic regurgitation and ischemic heart disease.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Placebo Comparator
Active Comparator
Valve replacement according to guideline parameters
Early valve replacement
One group will be referred for surgery according according to indications for mitral valve replacement in European guidelines for valvular heart diseases published in 2017 and will have speckle tracking echocardiography before surgery and 6 months later for comparison.
The other group will include patients with severe asymptomatic mitral regurgitation who have left atrial or left ventricular dysfunction according to speckle tracking echocardiography and will be referred to surgery, then speckle tracking echo will be performed 6 months later.